Certara’s Karen Yeo discusses FDA’s draft guidance to include pregnant and breastfeeding women in clinical trials and how modeling supports safer dosing.
RADNOR, PA— 2025年11月6日-- Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in model-informed drug development, today reported its financial results for the third quarter…
